MECO Remains Committed to Contributing to the Fight Against COVID-19
As the world is approaching the one-year anniversary of being in lockdown from the novel coronavirus, MECO remains steadfast in our commitment to contributing to the global response to end the pandemic.
Producing over 25 million gallons of pharmaceutical grade water daily, MECO’s systems are critical to the biopharmaceutical industry as it continues to combat the spread of COVID-19 around the world. MECO water is used in the manufacturing of the COVID-19 vaccines, along with the syringes, packaging, therapeutics and testing kits that go into distributing the vaccines worldwide. These operations are highly reliant on reliable water purification systems and MECO is proud to be able to provide that piece of the puzzle.
As the massive demand for high purity water grows, we are committed to meeting those needs and doing our part to stop the spread of COVID-19. For more information on how MECO is providing essential services to the biopharmaceutical industry and the manufacture of the COVID-19 vaccines, visit https://www.meco.com/news/.
MECO is a world leader in the design and construction of engineered products for water purification serving industries where water is considered a critical utility. MECO designs and constructs proprietary machinery and systems for the biopharmaceutical industry where ultrapure water is the primary ingredient in the manufacture of drugs and medical devices.
MECO also manufactures a broad base of desalination technologies to the offshore oil and gas industry for use on platforms, drilling rigs and remote locations. Armed forces of the United States and other countries have used MECO products since World War II.